Wednesday, October 31, 2012

Gene variant predicts lymphoma treatment response

German researchers have identified a gene variant that significantly influences the outcome of methotrexate therapy for primary central nervous system lymphoma.

via Med Wire News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)